Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease.

被引：1
|
作者：
Mukherji, Reetu
Noel, Marcus Smith
He, Aiwu Ruth
Weinberg, Benjamin Adam
Weiner, Louis M.
Marshall, John
机构：
[1] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
3282-415-6705; 613-545-552; 130-540-543; 261-492-11294; 261-492-341; 283-237-255; 261-492-3532-2370; 17; 6; 4; 3; 2; 3604;
D O I：
10.1200/JCO.2024.42.3_suppl.TPS765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS765 / TPS765
页数：1
相关论文
共 50 条
  • [1] Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease.
    Mukherji, Reetu
    Wang, Hongkun
    He, Aiwu Ruth
    Noel, Marcus Smith
    Weinberg, Benjamin Adam
    Weiner, Louis M.
    Marshall, John
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS850 - TPS850
  • [2] ctDNA, a Biomarker of Residual Disease and Tumor Response in Gastrointestinal Cancers
    Parikh, Aparna Raj
    ONCOLOGIST, 2019, 24 : S2 - S2
  • [3] Microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) across gastrointestinal (GI) malignancies.
    Winters, Harrison David
    Sackstein, Paul
    Weinberg, Benjamin Adam
    Debnath, Dipanjan
    Geng, Xue
    Wang, Hongkun
    Chintalacheruvu, Saavan
    Marshall, John
    He, Aiwu Ruth
    Noel, Marcus Smith
    Mukherji, Reetu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 176 - 176
  • [4] Serial circulating tumor DNA (ctDNA) monitoring to predict response to treatment in metastatic gastrointestinal cancers
    Parikh, A.
    Kanter, K.
    Mojtahed, A.
    Schneider, J.
    Van Seventer, E.
    Fish, M.
    Allen, J.
    Blaszkowsky, L.
    Wo, J.
    Clark, J.
    Giantonio, B.
    Goyal, L.
    Hong, T.
    Nipp, R.
    Roeland, E.
    Weekes, C.
    Zhu, A.
    Ryan, D.
    Fetter, I.
    Horick, N.
    Corcoran, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] The Role of Circulating Tumor DNA in Evaluating Minimal Residual Disease in Luminal Gastrointestinal Malignancies
    Ueberroth, Benjamin E.
    Jones, Jeremy C.
    Bekaii-Saab, Tanios
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 444 - +
  • [6] Circulating Tumor DNA as a Marker of Minimal Residual Disease
    Fangman, Ben
    Raghav, Kanwal
    Kopetz, Scott
    ONCOLOGY-NEW YORK, 2022, 36 (10): : 600 - 603
  • [7] Real-world microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) in pancreatic adenocarcinoma (PDAC).
    Li, Peter Chi-Win
    Winters, Harrison David
    Geng, Xue
    Wang, Hongkun
    Noel, Marcus Smith
    He, Aiwu Ruth
    Weinberg, Benjamin Adam
    Marshall, John
    Tesfaye, Anteneh A.
    Mukherji, Reetu
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 696 - 696
  • [8] Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Re-I Chin
    Kevin Chen
    Abul Usmani
    Chanelle Chua
    Peter K. Harris
    Michael S. Binkley
    Tej D. Azad
    Jonathan C. Dudley
    Aadel A. Chaudhuri
    Molecular Diagnosis & Therapy, 2019, 23 : 311 - 331
  • [9] Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I
    Chen, Kevin
    Usmani, Abul
    Chua, Chanelle
    Harris, Peter K.
    Binkley, Michael S.
    Azad, Tej D.
    Dudley, Jonathan C.
    Chaudhuri, Aadel A.
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (03) : 311 - 331
  • [10] Circulating Tumor DNA (ctDNA) as a Marker of Progressive Disease in Patients with Advanced Lung Cancer
    Ulrich, B.
    Paweletz, C.
    Milan, M.
    Oxnard, G.
    Janne, P.
    Rotow, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S416 - S416
12345